c ebpβ-lip drug Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module C/EBPβ sustains the oncogenic program
C EBP sustains the oncogenic program of AML cells by cooperating with MYB and co activator p300 in a transcriptional module Experimental Hematology C EBP LIP mediated activation of the malate aspartate shuttle sensitizes cells to glycolysis inhibition ScienceDirect Alignment of CEBPb isoforms LAP*, LAP, and LIP created and annotated Download Scientific Diagram C EBP Antibody Sampler Kit Cell Signaling Technology A review of C EBP : a potential novel target for solid tumor intervention Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



